LBA21InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naïve disease - An International Rare Cancers Initiative (IRCI) trial. (23rd October 2018) - Rao, S; Sclafani, F; Eng, C; Grønlie Guren, M; Adams, R A; Benson, A; Sebag-Montefiore, D; Segelov, E; Bryant, A; Peckitt, C; Roy, A; Seymour, M T; et al.